Gilbert Wagener
Hoofd Techniek/Wetenschap/O&O bij PHARNEXT SCA
Actieve functies van Gilbert Wagener
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PHARNEXT SCA | Hoofd Techniek/Wetenschap/O&O | 15-06-2023 | - |
Loopbaan van Gilbert Wagener
Eerdere bekende functies van Gilbert Wagener
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - | - |
Cell2B - Advanced Therapeutics SA
 Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Gilbert Wagener
| Philipps University of Marburg | Doctorate Degree |
| University of Basel | Masters Business Admin |
| Erasmus University Rotterdam | Doctorate Degree |
Statistieken
Internationaal
| Portugal | 2 |
| Duitsland | 2 |
| Zwitserland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Cell2B - Advanced Therapeutics SA
Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Gilbert Wagener
- Ervaring
